Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Q1 2025 Unaudited Interim Report of the Krka Group and Krka Company.pdfQ1 2025 Unaudited Interim Report of the Krka Group and Krka Company
  2. Press Release.pdfPress Release

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 26 / 2025
Date of issue: 2025-05-15
Short name of the issuer
KRKA
Subject
Unaudited Interim Report of the Krka Group and the Krka, d. d., Novo mesto for the first quarter of 2025
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Based on Article 26 of the Rules of the Ljubljana Stock Exchange d.d. company Krka, d. d., Novo mesto publishes the Unaudited interim Report of the Krka Group and Krka, d. d., Novo mesto for the first quarter of 2025.

The report will be published on the Company's website (www.krka.biz) from 15 May 2025 onwards, for a minimum period of 5 years.
Annexes
File Description
Q1 2025 Unaudited Interim Report of the Krka Group and Krka Company.pdf
Q1 2025 Unaudited Interim Report of the Krka Group and Krka Company.pdf
Q1 2025 Unaudited Interim Report of the Krka Group and Krka Company
Press Release.pdf
Press Release.pdf
Press Release

KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKA Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
8501 Nove Mesto
(post code) (city)
Smarjeska 6
(street) (number)
+386 7 331 21 11 +386 7 332 15 37
(phone number) (fax)
(e-mail) (web site)
nie dotyczy
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2025-05-15 Jože Colarič President of the Management Board and CEO
20250515_082126_2140469715_Press_Release.pdf

20250515_082126_2140469715_Q1_2025_Unaudited_Interim_Report_of_the_Krka_Group_and_Krka_Company.pdf